These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35852470)

  • 1. Insulin Resistance and Cognitive Impairment: Evidence From Neuroimaging.
    Cui Y; Tang TY; Lu CQ; Ju S
    J Magn Reson Imaging; 2022 Dec; 56(6):1621-1649. PubMed ID: 35852470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral changes improved by physical activity during cognitive decline: A systematic review on MRI studies.
    Haeger A; Costa AS; Schulz JB; Reetz K
    Neuroimage Clin; 2019; 23():101933. PubMed ID: 31491837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.
    Baker LD; Cross DJ; Minoshima S; Belongia D; Watson GS; Craft S
    Arch Neurol; 2011 Jan; 68(1):51-7. PubMed ID: 20837822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral Pathology and Cognition in Diabetes: The Merits of Multiparametric Neuroimaging.
    van Bussel FCG; Backes WH; Hofman PAM; van Oostenbrugge RJ; van Boxtel MPJ; Verhey FRJ; Steinbusch HWM; Schram MT; Stehouwer CDA; Wildberger JE; Jansen JFA
    Front Neurosci; 2017; 11():188. PubMed ID: 28424581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.
    Willette AA; Bendlin BB; Starks EJ; Birdsill AC; Johnson SC; Christian BT; Okonkwo OC; La Rue A; Hermann BP; Koscik RL; Jonaitis EM; Sager MA; Asthana S
    JAMA Neurol; 2015 Sep; 72(9):1013-20. PubMed ID: 26214150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance predicts medial temporal hypermetabolism in mild cognitive impairment conversion to Alzheimer disease.
    Willette AA; Modanlo N; Kapogiannis D;
    Diabetes; 2015 Jun; 64(6):1933-40. PubMed ID: 25576061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2017 Apr; 13(4):e1-e85. PubMed ID: 28342697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral versus Central Index of Metabolic Dysfunction and Associations with Clinical and Pathological Outcomes in Alzheimer's Disease.
    McLimans KE; Webb JL; Anantharam V; Kanthasamy A; Willette AA;
    J Alzheimers Dis; 2017; 60(4):1313-1324. PubMed ID: 28968233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there an association between peripheral immune markers and structural/functional neuroimaging findings?
    Frodl T; Amico F
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():295-303. PubMed ID: 23313563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White Matter Hyperintensities and Cognitive Impairment in Healthy and Pathological Aging: A Quantified Brain MRI Study.
    Kaskikallio A; Karrasch M; Koikkalainen J; Lötjönen J; Rinne JO; Tuokkola T; Parkkola R; Grönholm-Nyman P
    Dement Geriatr Cogn Disord; 2019; 48(5-6):297-307. PubMed ID: 32209796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and Alzheimer's disease: molecular links & clinical implications.
    Neumann KF; Rojo L; Navarrete LP; Farías G; Reyes P; Maccioni RB
    Curr Alzheimer Res; 2008 Oct; 5(5):438-47. PubMed ID: 18855585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral perfusion alterations in type 2 diabetes and its relation to insulin resistance and cognitive dysfunction.
    Cui Y; Liang X; Gu H; Hu Y; Zhao Z; Yang XY; Qian C; Yang Y; Teng GJ
    Brain Imaging Behav; 2017 Oct; 11(5):1248-1257. PubMed ID: 27714551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the association between brain atrophy, hypometabolism, and cognitive decline in Alzheimer's disease: a PET/MRI study.
    Chen Y; Wang J; Cui C; Su Y; Jing D; Wu L; Liang P; Liang Z
    Aging (Albany NY); 2021 Feb; 13(5):7228-7246. PubMed ID: 33640881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampus-Based Dynamic Functional Connectivity Mapping in the Early Stages of Alzheimer's Disease.
    Wang J; Wang P; Jiang Y; Wang Z; Zhang H; Li H; Biswal BB
    J Alzheimers Dis; 2022; 85(4):1795-1806. PubMed ID: 34958033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.
    Nho K; Kueider-Paisley A; Ahmad S; MahmoudianDehkordi S; Arnold M; Risacher SL; Louie G; Blach C; Baillie R; Han X; Kastenmüller G; Trojanowski JQ; Shaw LM; Weiner MW; Doraiswamy PM; van Duijn C; Saykin AJ; Kaddurah-Daouk R;
    JAMA Netw Open; 2019 Jul; 2(7):e197978. PubMed ID: 31365104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease.
    He P; Qu H; Cai M; Liu W; Gu X; Ma Q
    Neural Plast; 2022; 2022():8461235. PubMed ID: 35111220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Stress Alters Antioxidant Systems, Suppresses the Adiponectin Receptor 1 and Induces Alzheimer's Like Pathology in Mice Brain.
    Hahm JR; Jo MH; Ullah R; Kim MW; Kim MO
    Cells; 2020 Jan; 9(1):. PubMed ID: 31963819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.